ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.
India Glycols posted a record Q1 with 19% net revenue growth and 32% PAT growth, driven by its Bio-Pharma segment. Management is aggressively pivoting toward a premium-led consumer model through restructuring and new liquor brand partnerships.
India Glycols reported strong Q1FY27 results with 19% Gross Revenue growth and 32% PAT growth, driven by a diversified portfolio and a demerger strategy into three focused platforms.
India Glycols Ltd reported revenue from operations of ₹2,988 Cr (+19.4% YoY) and net profit of ₹96.8 Cr (+32.2% YoY) for Q1 FY27.
India Glycols reported a strong FY26 with net revenue of ₹4,211cr (up 11.8%) and PAT of ₹293cr (up 26.8%). Strategy focuses on premiumization in spirits and expanding bio-based chemicals.
India Glycols delivered solid FY26 performance led by portable spirits and biofuels, successfully deleveraging the balance sheet through promoter equity infusion and internal accruals while shifting toward a premium-led liquor portfolio.
India Glycols delivered strong FY26 performance with 11.8% Net Revenue growth and 26.8% PAT growth. Management is executing a three-way demerger into Chemicals, Spirits/Bio-Fuel, and Bio-Pharma entities.
India Glycols Ltd reported revenue from operations of ₹2,360 Cr (+7.8% YoY) and net profit of ₹86.9 Cr (+35.8% YoY) for Q4 FY26.